MEDIGENE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.405 EUR | -0.71% |
|
-2.43% | -7.87% |
| May. 15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
| May. 14 | Medigene Ag Maintains Earnings Guidance for 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDIGENE AG | Bio Therapeutic Drugs | -0.71% | -2.43% | -7.87% | -12.19% | -83.15% | 37.78M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MDG1 Stock
- Charts Medigene AG
- Comparison Chart
